Literature DB >> 30210724

Severe Nodulocystic Acne not Responding to Isotretinoin Therapy Successfully Treated with Oral Dapsone.

Lutfi Al-Kathiri1, Tasneem Al-Najjar1.   

Abstract

Nodulocystic acne is a severe form of acne which can result in significant damage to the skin with great impact on quality of life. Oral isotretinoin considered to be the best treatment for such cases. Although it has a high rate of success and its efficacy is well established in the treatment of nodulocystic acne, it may occasionally fail to control the disease. We report a case of a patient who presented to our skin clinic with severe facial nodulocystic acne in which treatment with isotretinoin failed to achieve disease control and caused worsening of his baseline condition. Therefore, oral dapsone was administered as an alternative treatment, and we reached a complete remission of acne lesions within six months. Oral dapsone could be an adequate and safe drug in severe acne, and it might also be a promising and hopeful alternative treatment for nodulocystic acne when isotretinoin fails.

Entities:  

Keywords:  Acne Conglobata; Acne Vulgaris; Dapsone; Isotretinoin

Year:  2018        PMID: 30210724      PMCID: PMC6131924          DOI: 10.5001/omj.2018.79

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  13 in total

Review 1.  Management of severe acne.

Authors:  C C Zouboulis; V Bettoli
Journal:  Br J Dermatol       Date:  2015-07       Impact factor: 9.302

2.  Usefulness of dapsone for the treatment of Asian severe acne.

Authors:  Makiko Wakabayashi; Norikazu Fujii; Noriki Fujimoto; Toshihiro Tanaka
Journal:  J Dermatol       Date:  2013-04-27       Impact factor: 4.005

3.  Impact of acne on quality of life of students at sultan qaboos university.

Authors:  Asma Al-Shidhani; Samia Al-Rashdi; Hamdan Al-Habsi; Syed Rizvi
Journal:  Oman Med J       Date:  2015-01

Review 4.  Guidelines of care for the management of acne vulgaris.

Authors:  Andrea L Zaenglein; Arun L Pathy; Bethanee J Schlosser; Ali Alikhan; Hilary E Baldwin; Diane S Berson; Whitney P Bowe; Emmy M Graber; Julie C Harper; Sewon Kang; Jonette E Keri; James J Leyden; Rachel V Reynolds; Nanette B Silverberg; Linda F Stein Gold; Megha M Tollefson; Jonathan S Weiss; Nancy C Dolan; Andrew A Sagan; Mackenzie Stern; Kevin M Boyer; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2016-02-17       Impact factor: 11.527

5.  A comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne.

Authors:  J S Prendiville; R A Logan; R Russell-Jones
Journal:  Clin Exp Dermatol       Date:  1988-03       Impact factor: 3.470

Review 6.  Acne vulgaris: pathogenesis, treatment, and needs assessment.

Authors:  Siri Knutsen-Larson; Annelise L Dawson; Cory A Dunnick; Robert P Dellavalle
Journal:  Dermatol Clin       Date:  2011-10-21       Impact factor: 3.478

7.  Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction.

Authors:  S M Debol; M J Herron; R D Nelson
Journal:  J Leukoc Biol       Date:  1997-12       Impact factor: 4.962

8.  Innovative use of dapsone.

Authors:  V E Gottfried Wozel
Journal:  Dermatol Clin       Date:  2010-07       Impact factor: 3.478

Review 9.  Diagnosis and treatment of acne.

Authors:  Stephen Titus; Joshua Hodge
Journal:  Am Fam Physician       Date:  2012-10-15       Impact factor: 3.292

Review 10.  Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.

Authors:  Mira Stotland; Alan R Shalita; Robert F Kissling
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.